Analysts Set Average Price Target of $10.50 for Adverum Biotechnologies
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) has recently garnered attention from analysts, who have established a consensus rating of “Hold” for the biotechnology firm. According to MarketBeat Ratings, this rating comes from…